Waldencast (NASDAQ:WALD – Get Free Report) is projected to issue its quarterly earnings data after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $70.43 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Waldencast Stock Up 3.5 %
NASDAQ:WALD opened at $3.21 on Monday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. The firm has a fifty day simple moving average of $3.24 and a two-hundred day simple moving average of $3.47. Waldencast has a 12 month low of $2.41 and a 12 month high of $7.54.
Wall Street Analysts Forecast Growth
WALD has been the subject of a number of analyst reports. Telsey Advisory Group reiterated an “outperform” rating and set a $6.00 price objective on shares of Waldencast in a report on Tuesday, March 11th. DA Davidson boosted their price target on shares of Waldencast from $7.25 to $7.50 and gave the stock a “buy” rating in a report on Wednesday, December 4th. TD Cowen started coverage on shares of Waldencast in a report on Monday, December 16th. They set a “hold” rating and a $4.30 price target on the stock. Finally, Canaccord Genuity Group boosted their price target on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, November 22nd. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Waldencast currently has a consensus rating of “Moderate Buy” and a consensus target price of $5.76.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
- Five stocks we like better than Waldencast
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How to Build the Ultimate Everything ETF Portfolio
- What is a Stock Market Index and How Do You Use Them?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.